Deconstructing tolerance with clobazam: Post hoc analyses from an open-label extension study

OBJECTIVE: To evaluate potential development of tolerance to adjunctive clobazam in patients with Lennox-Gastaut syndrome. METHODS: Eligible patients enrolled in open-label extension study OV-1004, which continued until clobazam was commercially available in the United States or for a maximum of 2 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Gidal, Barry E., Wechsler, Robert T., Sankar, Raman, Montouris, Georgia D., White, H. Steve, Cloyd, James C., Kane, Mary Clare, Peng, Guangbin, Tworek, David M., Shen, Vivienne, Isojarvi, Jouko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089527/
https://www.ncbi.nlm.nih.gov/pubmed/27683846
http://dx.doi.org/10.1212/WNL.0000000000003253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089527/
https://www.ncbi.nlm.nih.gov/pubmed/27683846
http://dx.doi.org/10.1212/WNL.0000000000003253

Ejemplares similares